BRIEF-Paion completes patient recruitment in phase III study with Remimazolam
* Announced on Monday successful completion of recruitment in the U.S. Phase III clinical trial of Remimazolam, an ultra-short-acting sedative/anesthetic, for procedural sedation in patients undergoing colonoscopy
No comments:
Post a Comment